BeStock  
Stocks › Medical Devices › IART

Integra Lifesciences IART

US equityMarket cap rank #3233Medical DevicesBrain-Computer Interface
$13.00 −$0.32 (-2.40%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.00 0.00%
Open$13.19
Prev close$13.32
Day range$12.98 – $13.46
Volume1.41M
Market cap$1.01B
P/E (TTM)–
Dividend yield–

IART Stock News

Headlines matching Integra Lifesciences or the IART ticker, most recent first.

  • J.P. Morgan Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $17 PositiveMarket news · 5 Aug 2026 · Direct mention
  • Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $19Market news · 13 Aug 2026 · Direct mention
  • BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $18 NegativeMarket news · 30 Jul 2026 · Direct mention
  • Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $18 PositiveMarket news · 30 Jul 2026 · Direct mention
  • Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $19 PositiveMarket news · 16 Jul 2026 · Direct mention
  • BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19Market news · 10 Jul 2026 · Direct mention
  • Argus Research Upgrades Integra Lifesciences(IART.US) to Buy Rating, Announces Target Price $25 PositiveMarket news · 18 Jun 2026 · Direct mention
  • Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $15 PositiveMarket news · 6 May 2026 · Direct mention
  • Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $11 PositiveMarket news · 6 May 2026 · Direct mention
  • Citi Upgrades Integra Lifesciences(IART.US) to Hold Rating, Raises Target Price to $16 PositiveMarket news · 28 May 2026 · Direct mention
  • BofA Securities Initiates Integra Lifesciences(IART.US) With Sell RatingMarket news · 14 May 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)TipRanks · 14 May 2026 · Direct mention
  • Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $9Market news · 7 Apr 2026 · Direct mention
  • Argus Research Downgrades Integra Lifesciences(IART.US) to Hold Rating NegativeMarket news · 15 Apr 2026 · Direct mention
  • Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $12 NegativeMarket news · 15 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IART.

Leave a comment

Scroll to Top